Navigation Links
Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
Date:6/12/2012

EDISON, N.J., June 12, 2012 /PRNewswire/ -- Oriel STAT A MATRIX has announced the appointment of Dr. Paul Landesman as Managing Director, Medical Devices and Life Sciences Practice.

In his new position, Dr. Landesman will be responsible for strategic leadership and managerial oversight of this practice.  He will also provide consultative oversight for the firm's delivery of regulatory, quality assurance, cost optimization, and best business practices for organizations in the pharmaceutical, medical device, combination products, and biotechnology sectors.  

Oriel STAT A MATRIX CEO Alan Marash noted, "Dr. Landesman's depth of industry knowledge and experience adds enormous strength to the firm's medical devices and life sciences practice. We look forward to having Paul identify new growth opportunities and shepherd the firm to the next level of knowledge leadership, customer service, performance, and professionalism."

Commenting on his new role at Oriel STAT A MATRIX, Dr. Landesman added, "Oriel STAT A MATRIX has succeeded in building a strong and well-recognized practice in the life sciences community, providing an excellent platform for future growth to meet the compliance and business requirements for our customers and the patients whom they serve."

Dr. Landesman joins Oriel STAT A MATRIX from Allergan Medical in Santa Barbara, CA, where he was a Senior Director of Quality Systems and Risk Management.   He has over 30 years of experience in quality, regulatory affairs, and patient safety in the medical device, pharmaceutical, and biotech industries, and has worked with the FDA and other global regulatory bodies in a wide variety of capacities.  In addition to his most recent position at Allergan, Dr. Landesman has worked with Abbott Laboratories, Hospira, and Amgen.

Dr. Landesman holds a BS in chemistry from the University of Massachusetts‒Dartmouth and a PhD in Medicinal Chemistry from the University of Buffalo.  He also served as Associate Director of the Clinical Laboratories at The Ohio State University Hospitals.  

About Oriel STAT A MATRIX

Since 1968, Oriel STAT A MATRIX has provided organizations with best-in-class performance improvement training and consulting—including FDA-regulated services, implementation of ISO 9000, and continual improvement methods such as Lean Six Sigma—that enhance financial results and customer satisfaction.   

In 1978, US FDA regulators chose Oriel STAT A MATRIX to work with the agency in rewriting the good manufacturing practice (GMP) regulations, the precursor to the current GMP (CGMP)/quality system regulations (QSR). The firm was then selected to train FDA compliance investigators in the new regulations. Since then, Oriel STAT A MATRIX has been a global leader in implementing quality and regulatory requirements at pharmaceutical, biotechnology, and medical device companies, as well as at hospitals and other healthcare provider organizations.    

Oriel STAT A MATRIX has offices in more than 18 countries and a diversified customer base that spans the globe and represents every economic sector.

For further information about Oriel STAT A MATRIX, please visit www.orielstat.com or call 732.548.0600.


'/>"/>
SOURCE Oriel STAT A MATRIX
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
2. Global BioClinical Welcomes Jennifer Maas as Senior Consultant
3. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
4. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
5. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
6. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
7. Post-Recession, the Global Market for Surgical Equipment Picks Up Speed, Particularly In China and Emerging Economies
8. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
9. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
10. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
11. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):